|
1
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: GLOBOCAN 2008, Cancer Incidence and
Mortality Worldwide: IARC CancerBase No. 10. IARC Press; Lyon:
2008
|
|
2
|
Frazer IH: Prevention of cervical cancer
through papillomavirus vaccination. Nat Rev Immunol. 4:46–54. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sankaranarayanan R and Ferlay J: Worldwide
burden of gynaecological cancer: the size of the problem. Best
Pract Res Clin Obstet Gynaecol. 20:207–225. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Vousden KH: Human papillomaviruses and
cervical carcinoma. Cancer Cells. 1:43–50. 1989.PubMed/NCBI
|
|
5
|
Vousden KH: Human papillomavirus
oncoproteins. Semin Cancer Biol. 1:415–424. 1990.
|
|
6
|
zur Hausen H: Human papillomaviruses in
the pathogenesis of anogenital cancer. Virology. 184:9–13.
1991.PubMed/NCBI
|
|
7
|
Munoz N, Bosch FX, de Sanjose S, et al:
Risk factors for cervical intraepithelial neoplasia grade
III/carcinoma in situ in Spain and Colombia. Cancer Epidemiol
Biomarkers Prev. 2:423–431. 1993.PubMed/NCBI
|
|
8
|
Munoz N, Castellsague X, de Gonzalez AB
and Gissmann L: Chapter 1: HPV in the etiology of human cancer.
Vaccine. 24(Suppl 3): S1–S10. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bosch FX, Munoz N, de Sanjose S, et al:
Human papillomavirus and cervical intraepithelial neoplasia grade
III/carcinoma in situ: a case-control study in Spain and Colombia.
Cancer Epidemiol Biomarkers Prev. 2:415–422. 1993.PubMed/NCBI
|
|
10
|
Franco EL, Rohan TE and Villa LL:
Epidemiologic evidence and human papillomavirus infection as a
necessary cause of cervical cancer. J Natl Cancer Inst. 91:506–511.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Castellsague X, Bosch FX and Munoz N:
Environmental co-factors in HPV carcinogenesis. Virus Res.
89:191–199. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Matos A, Moutinho J, Pinto D and Medeiros
R: The influence of smoking and other cofactors on the time to
onset to cervical cancer in a southern European population. Eur J
Cancer Prev. 14:485–491. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Medeiros R, Prazeres H, Pinto D, et al:
Characterization of HPV genotype profile in squamous cervical
lesions in Portugal, a southern European population at high risk of
cervical cancer. Eur J Cancer Prev. 14:467–471. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sanlioglu S, Benson P and Engelhardt JF:
Loss of ATM function enhances recombinant adeno-associated virus
transduction and integration through pathways similar to UV
irradiation. Virology. 268:68–78. 2000. View Article : Google Scholar
|
|
15
|
Dehart JL, Andersen JL, Zimmerman ES, et
al: The ataxia telangiectasia-mutated and Rad3-related protein is
dispensable for retroviral integration. J Virol. 79:1389–1396.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Skalka AM and Katz RA: Retroviral DNA
integration and the DNA damage response. Cell Death Differ.
12(Suppl 1): S971–S978. 2005. View Article : Google Scholar
|
|
17
|
Pett M and Coleman N: Integration of
high-risk human papillomavirus: a key event in cervical
carcinogenesis? J Pathol. 212:356–367. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Costa S, Pinto D, Pereira D, et al: DNA
repair polymorphisms might contribute differentially on familial
and sporadic breast cancer susceptibility: a study on a Portuguese
population. Breast Cancer Res Treat. 103:209–217. 2007. View Article : Google Scholar
|
|
19
|
Bork P, Hofmann K, Bucher P, Neuwald AF,
Altschul SF and Koonin EV: A superfamily of conserved domains in
DNA damage-responsive cell cycle checkpoint proteins. FASEB J.
11:68–76. 1997.PubMed/NCBI
|
|
20
|
Meulmeester E, Pereg Y, Shiloh Y and
Jochemsen AG: ATM-mediated phosphorylations inhibit Mdmx/Mdm2
stabilization by HAUSP in favor of p53 activation. Cell Cycle.
4:1166–1170. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Shiloh Y: ATM and related protein kinases:
safeguarding genome integrity. Nat Rev Cancer. 3:155–168. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Callebaut I and Mornon JP: From BRCA1 to
RAP1: a widespread BRCT module closely associated with DNA repair.
FEBS Lett. 400:25–30. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Schultz LB, Chehab NH, Malikzay A and
Halazonetis TD: p53 binding protein 1 (53BP1) is an early
participant in the cellular response to DNA double-strand breaks. J
Cell Biol. 151:1381–1390. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Rappold I, Iwabuchi K, Date T and Chen J:
Tumor suppressor p53 binding protein 1 (53BP1) is involved in DNA
damage-signaling pathways. J Cell Biol. 153:613–620. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Anderson L, Henderson C and Adachi Y:
Phosphorylation and rapid relocalization of 53BP1 to nuclear foci
upon DNA damage. Mol Cell Biol. 21:1719–1729. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mochan TA, Venere M, DiTullio RA Jr and
Halazonetis TD: 53BP1 and NFBD1/MDC1-Nbs1 function in parallel
interacting pathways activating ataxia-telangiectasia mutated (ATM)
in response to DNA damage. Cancer Res. 63:8586–8591.
2003.PubMed/NCBI
|
|
27
|
Mochan TA, Venere M, DiTullio RA Jr and
Halazonetis TD: 53BP1, an activator of ATM in response to DNA
damage. DNA Repair (Amst). 3:945–952. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Khanna KK and Chenevix-Trench G: ATM and
genome maintenance: defining its role in breast cancer
susceptibility. J Mammary Gland Biol Neoplasia. 9:247–262. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Khanna KK, Lavin MF, Jackson SP and
Mulhern TD: ATM, a central controller of cellular responses to DNA
damage. Cell Death Differ. 8:1052–1065. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gatti RA, Berkel I, Boder E, et al:
Localization of an ataxia-telangiectasia gene to chromosome
11q22–23. Nature. 336:577–580. 1988.
|
|
31
|
Chen G and Lee EYHP: The product of the
ATM gene is a 370-kDa nuclear phosphoprotein. J Biol Chem.
271:33693–33697. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Uziel T, Savitsky K, Platzer M, et al:
Genomic Organization of the ATM gene. Genomics. 33:317–320. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lavin MF and Shiloh Y: The genetic defect
in ataxia-telangiectasia. Annu Rev Immunol. 15:177–202. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Thorstenson YR, Roxas A, Kroiss R, et al:
Contributions of ATM mutations to familial breast and ovarian
cancer. Cancer Res. 63:3325–3333. 2003.PubMed/NCBI
|
|
35
|
Maillet P, Vaudan G, Chappuis P and
Sappino A: PCR-mediated detection of a polymorphism in the ATM
gene. Mol Cell Probes. 13:67–69. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Thorstenson YR, Shen P, Tusher VG, et al:
Global analysis of ATM polymorphism reveals significant functional
constraint. Am J Hum Genet. 69:396–412. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Angele S, Falconer A, Edwards SM, et al:
ATM polymorphisms as risk factors for prostate cancer development.
Br J Cancer. 91:783–787. 2004.PubMed/NCBI
|
|
38
|
Angele S, Romestaing P, Moullan N, et al:
ATM haplotypes and cellular response to DNA damage: association
with breast cancer risk and clinical radiosensitivity. Cancer Res.
63:8717–8725. 2003.PubMed/NCBI
|
|
39
|
Heikkinen K, Rapakko K, Karppinen SM,
Erkko H, Nieminen P and Winqvist R: Association of common ATM
polymorphism with bilateral breast cancer. Int J Cancer. 116:69–72.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Tapia T, Sanchez A, Vallejos M, et al: ATM
allelic variants associated to hereditary breast cancer in 94
Chilean women: susceptibility or ethnic influences? Breast Cancer
Res Treat. 107:281–288. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Maillet P, Chappuis PO, Vaudan G, et al: A
polymorphism in the ATM gene modulates the penetrance of hereditary
non-polyposis colorectal cancer. Int J Cancer. 88:928–931. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Meier M, den Boer ML, Hall AG, et al:
Relation between genetic variants of the ataxia
telangiectasia-mutated (ATM) gene, drug resistance, clinical
outcome and predisposition to childhood T-lineage acute
lymphoblastic leukaemia. Leukemia. 19:1887–1895. 2005. View Article : Google Scholar
|
|
43
|
Ma H, Hu Z, Zhai X, et al: Joint effects
of single nucleotide polymorphisms in P53BP1 and p53 on breast
cancer risk in a Chinese population. Carcinogenesis. 27:766–771.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Frank B, Hemminki K, Bermejo JL, et al:
TP53-binding protein variants and breast cancer risk: a
case-control study. Breast Cancer Res. 7:R502–R505. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Daniel R, Kao G, Taganov K, et al:
Evidence that the retroviral DNA integration process triggers an
ATR-dependent DNA damage response. Proc Natl Acad Sci USA.
100:4778–4783. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Iwabuchi K, Basu BP, Kysela B, et al:
Potential role for 53BP1 in DNA end-joining repair through direct
interaction with DNA. J Biol Chem. 278:36487–36495. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Derbyshire DJ, Basu BP, Serpell LC, et al:
Crystal structure of human 53BP1 BRCT domains bound to p53 tumour
suppressor. EMBO J. 21:3863–3872. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Medeiros R, Morais A, Vasconcelos A, et
al: The role of vitamin D receptor gene polymorphisms in the
susceptibility to prostate cancer of a southern European
population. J Hum Genet. 47:413–418. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Pinto D, Vasconcelos A, Costa S, et al:
HER2 polymorphism and breast cancer risk in Portugal. Eur J Cancer
Prev. 13:177–181. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Cardoso CS, Araujo HC, Cruz E, et al:
Haemochromatosis gene (HFE) mutations in viral-associated
neoplasia: Linkage to cervical cancer. Biochem Biophys Res Commun.
341:232–238. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Santos AM, Sousa H, Catarino R, et al:
TP53 codon 72 polymorphism and risk for cervical cancer in
Portugal. Cancer Genet Cytogenet. 159:143–147. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Pereira C, Pimentel-Nunes P, Brandao C,
Moreira-Dias L, Medeiros R and Dinis-Ribeiro M: COX-2 polymorphisms
and colorectal cancer risk: a strategy for chemoprevention. Eur J
Gastroenterol Hepatol. 22:607–613. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Sousa H, Pando M, Breda E, Catarino R and
Medeiros R: Role of the MDM2 SNP309 polymorphism in the initiation
and early age of onset of nasopharyngeal carcinoma. Mol Carcinog.
50:73–79. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Sousa H, Breda E, Santos AM, Catarino R,
Pinto D and Medeiros R: Genetic risk markers for nasopharyngeal
carcinoma in Portugal: tumor necrosis factor alpha -308G>A
polymorphism. DNA Cell Biol. 30:99–103. 2011. View Article : Google Scholar : PubMed/NCBI
|
